Healthtech startups raised $3.9 billion in Q3 2025, marking a sustained recovery as deal volume rose 12% and investors doubled down on later-stage, AI-enabled platforms. The median VC pre-money valuation climbed to a record of $38.5 million, reflecting rising valuations—even as deal activity and valuations remain below their 2021 peak. These trends signal renewed momentum in healthtech VC after two years of uneven funding activity. VC exit count hit an all-time high of 42 in the quarter, reflecting greater liquidity for smaller startups even as IPO activity paused.
Read the full article: PitchBook Q3 2025 Healthtech VC Trends //
Source: https://pitchbook.com/news/reports/q3-2025-healthtech-vc-trends